ArticleMolecules (Basel, Switzerland)2022
Identification of a Hydrogen-Sulfide-Releasing Isochroman-4-One Hybrid as a Cardioprotective Candidate for the Treatment of Cardiac Hypertrophy.
Yu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.